Mitchell Shirvan - Net Worth and Insider Trading
Mitchell Shirvan Net Worth
The estimated net worth of Mitchell Shirvan is at least $1,178 dollars as of 2026-09-10. Mitchell Shirvan is the CSO and CDO of Silexion Therapeutics Corp and owns about 2,789 shares of Silexion Therapeutics Corp (SLXN) stock worth over $1,178. Details can be seen in Mitchell Shirvan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mitchell Shirvan has not made any transactions after 2026-03-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mitchell Shirvan
Mitchell Shirvan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mitchell Shirvan owns 1 companies in total, including Silexion Therapeutics Corp (SLXN) .
Click here to see the complete history of Mitchell Shirvan’s form 4 insider trades.
Insider Ownership Summary of Mitchell Shirvan
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | 2026-03-26 | CSO and CDO |
Mitchell Shirvan Latest Holdings Summary
Mitchell Shirvan currently owns a total of 1 stock. Mitchell Shirvan owns 2,789 shares of Silexion Therapeutics Corp (SLXN) as of March 26, 2026, with a value of $1,178.
Latest Holdings of Mitchell Shirvan
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | 2026-03-26 | 2,789 | 0.42 | 1,178 |
Holding Weightings of Mitchell Shirvan
Mitchell Shirvan Form 4 Trading Tracker
According to the SEC Form 4 filings, Mitchell Shirvan has made a total of 1 transactions in Silexion Therapeutics Corp (SLXN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Silexion Therapeutics Corp is the sale of 2,282 shares on March 26, 2026, which brought Mitchell Shirvan around $31,032.
Insider Trading History of Mitchell Shirvan
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Mitchell Shirvan Trading Performance
Mitchell Shirvan Ownership Network
Ownership Network List of Mitchell Shirvan
Ownership Network Relation of Mitchell Shirvan
Mitchell Shirvan Owned Company Details
What does Silexion Therapeutics Corp do?
Who are the key executives at Silexion Therapeutics Corp?
Mitchell Shirvan is the CSO and CDO of Silexion Therapeutics Corp. Other key executives at Silexion Therapeutics Corp include 10 percent owner Leonard Potter , director & Chairman and CEO Ilan Hadar , and director & 10 percent owner Ilan Levin .
Silexion Therapeutics Corp (SLXN) Insider Trades Summary
Over the past 18 months, Mitchell Shirvan made 1 insider transaction in Silexion Therapeutics Corp (SLXN) with a net sale of 22,818.
In summary, during the past 3 months, insiders sold 0 shares of Silexion Therapeutics Corp (SLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,282 shares of Silexion Therapeutics Corp (SLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,282 shares.
Silexion Therapeutics Corp (SLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silexion Therapeutics Corp Insider Transactions
Mitchell Shirvan Mailing Address
Above is the net worth, insider trading, and ownership report for Mitchell Shirvan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mitchell Shirvan's mailing address is: Rehovot.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
